Exagen Newsroom

TD Cowen Maintains Exagen(XGN.US) With Buy Rating, Maintains Target Price $7

Moomoo NewsNov 13 09:31 ET

Exagen's Strategic Advancements and Market Potential Drive Buy Rating Amidst Upcoming ADVISE Test Launch

TipRanksNov 13 09:28 ET

CCORF Maintains Exagen(XGN.US) With Buy Rating, Maintains Target Price $5

Moomoo NewsNov 13 08:31 ET

BTIG Maintains Exagen(XGN.US) With Buy Rating, Maintains Target Price $5

Moomoo NewsNov 12 21:31 ET

KeyBanc Maintains Exagen(XGN.US) With Hold Rating

Moomoo NewsNov 12 20:31 ET

TD Cowen Maintains Exagen(XGN.US) With Buy Rating, Maintains Target Price $7

Moomoo NewsAug 6 08:36 ET

TD Cowen Maintains Exagen(XGN.US) With Buy Rating, Maintains Target Price $7

Moomoo NewsAug 5 20:32 ET

Exagen's Strong Q2 Performance and Promising Outlook Merit a Buy Rating

TipRanksAug 5 20:29 ET

Exagen Analyst Ratings

BenzingaMay 14 08:48 ET

Exagen's Strong Q1 Earnings and Growth Potential Justify Buy Rating

TipRanksMay 14 07:41 ET

Buy Rating Affirmed for Exagen Amid Strong Sales Growth and Promising Outlook

TipRanksMay 13 19:10 ET

Buy Rating Affirmed for Exagen on Strong Financials and Strategic Growth Initiatives

TipRanksMar 20 06:02 ET

Exagen's Strong Q4 Performance and Positive Outlook Justify Buy Rating

TipRanksMar 18 19:05 ET

Exagen (XGN) Receives a Buy From BTIG

TipRanksJan 2 09:55 ET

Exagen (XGN) Gets a Buy From BTIG

TipRanksDec 31, 2023 05:28 ET

Exagen (XGN) Gets a Buy From Cantor Fitzgerald

TipRanksNov 14, 2023 07:58 ET

Analysts Offer Insights on Healthcare Companies: Exagen (XGN) and Milestone Pharmaceuticals (MIST)

TipRanksNov 13, 2023 21:30 ET

Cantor Fitzgerald Reiterates Overweight on Exagen, Maintains $6 Price Target

BenzingaSep 26, 2023 12:02 ET

Exagen Analyst Ratings

BenzingaSep 26, 2023 12:01 ET

Cantor Fitzgerald Reiterates Overweight on Exagen, Maintains $6 Price Target

BenzingaAug 22, 2023 11:55 ET